ENDPOINTS

Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss

Zealand Pharma on Wednesday rolled out more Phase 1b data for its experimental GLP-1/GLP-2 drug, showing that higher doses could lead to more weight loss in people who are overweight or obese. The drug, called ...

Jun 18, 2025 - 19:20
 0
Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss
Zealand Pharma on Wednesday rolled out more Phase 1b data for its experimental GLP-1/GLP-2 drug, showing that higher doses could lead to more weight loss in people who are overweight or obese. The drug, called ...
Read More

Tags:

Previous Article

Watch Honda launch (and land) its 1st reusable rocket in this wild video

Next Article

Tick-borne diseases are booming – but we have new ways to fight them

Related Posts

Kennedy's doubts over vaccine placebos don't align with science, experts say

Kennedy's doubts over vaccine placebos don't align with...

Jun 12, 2025  0

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

Post-Hoc: AI bio needs to heed the overhyped history of...

May 22, 2025  0

KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’ 

KalVista says FDA delayed decision on HAE drug, citing ...

Jun 13, 2025  0